Overview
- Reports on clinical trials success and challenges
- Details the mechanism of drug resistance
- Includes supplementary material: sn.pub/extras
Part of the book series: SpringerBriefs in Applied Sciences and Technology (BRIEFSAPPLSCIENCES)
Part of the book sub series: Nanotheranostics (BRIEFSNANO)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (1 chapter)
-
Front Matter
Keywords
About this book
This Brief focuses on the cancer therapy available till date, from conventional drug delivery to nanomedicine in clinical trial. In addition, it reports on future generation based nanotherapeutics and cancer theranostic agent for effective therapeutic diagnosis and treatment. Breast cancer was chosen as the model system in this review. The authors give emphasis to multiple drug resistance (MDR) and its mechanism and how to overcome it using the nanoparticle approach.
Reviews
Authors and Affiliations
Bibliographic Information
Book Title: Nanomedicine for Cancer Therapy
Book Subtitle: From Chemotherapeutic to Hyperthermia-Based Therapy
Authors: Piyush Kumar, Rohit Srivastava
Series Title: SpringerBriefs in Applied Sciences and Technology
DOI: https://doi.org/10.1007/978-3-319-45826-7
Publisher: Springer Cham
eBook Packages: Engineering, Engineering (R0)
Copyright Information: The Author(s) 2017
Softcover ISBN: 978-3-319-45825-0Published: 01 December 2016
eBook ISBN: 978-3-319-45826-7Published: 21 November 2016
Series ISSN: 2191-530X
Series E-ISSN: 2191-5318
Edition Number: 1
Number of Pages: VIII, 68
Number of Illustrations: 15 b/w illustrations, 2 illustrations in colour
Topics: Nanotechnology, Cancer Research, Biomedical Engineering and Bioengineering, Regenerative Medicine/Tissue Engineering